Tencent's Hy3 drops the license restrictions that blocked EU and U.K. deployments, cuts hallucination rates in half, and runs ...

Moving to a private cloud won't save you; AI is uncovering software flaws faster than open-source maintainers can ever patch ...

Anthropic's Claude platform went down for tens of thousands of users on Tuesday, June 23, as Downdetector reports surged past 8,000 in the United States alone — the latest in a documented run of ...

When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising ...

Healthcare claims often fail due to small data errors. Mukesh Kumar Mishra has built cloud-based validation and anomaly ...

In March 2022, attackers drained 173,600 ETH and 25.5 million USDC from the Ronin Bridge. However, the mechanics matter here.

AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...

Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody ...

Learn why Australian businesses are moving from large apps to microservices and how managed Kubernetes can make that shift ...

Good day, and thank you for standing by. Welcome to the Anterix Fourth Quarter Fiscal 2026 Investor Update Call. [Operator Instructions] Please be advised that today's conference is being recorded.